Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Details - Options by exercise price (Details - Options Outstanding and Exercisable)

v3.22.0.1
Stockholders' Equity (Details - Options by exercise price (Details - Options Outstanding and Exercisable) - Equity Option [Member]
12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Options Outstanding, Beginning | shares 210,000
Weighted Average Exercise Price Outstanding, Beginning | $ / shares $ 9.61
Options Outstanding Beginning 9 years 7 months 9 days
Number of Options Granted | shares 210,000
Weighted Average Exercise Price Granted | $ / shares $ 5.93
Number of Options Exercised | shares
Weighted Average Exercise Price Exercised | $ / shares
Number of Options Forfeited | shares
Weighted Average Exercise Price Forfeited | $ / shares
Number of Options Outstanding, Ending | shares 420,000
Weighted Average Exercise Price Outstanding, Ending | $ / shares $ 5.82
Options Outstanding, Ending 8 years 6 months 21 days
Aggregate intrinsic value options outstanding | $ $ 615,300
Number of Options Vested | shares 315,288
Weighted Average Exercise Price Vested | $ / shares $ 4.80
Options Vested 8 years 25 days
Aggregate intrinsic value options vested | $ $ 153,825
Number of Options Exercisable, Ending | shares 315,288
Weighted Average Exercise Price Exercisable, Ending | $ / shares $ 4.80
Options Exercisable 8 years 25 days
Aggregate intrinsic value options exercisable | $ $ 153,825